Your browser doesn't support javascript.
loading
Prostate-specific antigen velocity in a prospective prostate cancer screening study of men with genetic predisposition.
Mikropoulos, Christos; Selkirk, Christina G Hutten; Saya, Sibel; Bancroft, Elizabeth; Vertosick, Emily; Dadaev, Tokhir; Brendler, Charles; Page, Elizabeth; Dias, Alexander; Evans, D Gareth; Rothwell, Jeanette; Maehle, Lovise; Axcrona, Karol; Richardson, Kate; Eccles, Diana; Jensen, Thomas; Osther, Palle J; van Asperen, Christi J; Vasen, Hans; Kiemeney, Lambertus A; Ringelberg, Janneke; Cybulski, Cezary; Wokolorczyk, Dominika; Hart, Rachel; Glover, Wayne; Lam, Jimmy; Taylor, Louise; Salinas, Monica; Feliubadaló, Lidia; Oldenburg, Rogier; Cremers, Ruben; Verhaegh, Gerald; van Zelst-Stams, Wendy A; Oosterwijk, Jan C; Cook, Jackie; Rosario, Derek J; Buys, Saundra S; Conner, Tom; Domchek, Susan; Powers, Jacquelyn; Ausems, Margreet Gem; Teixeira, Manuel R; Maia, Sofia; Izatt, Louise; Schmutzler, Rita; Rhiem, Kerstin; Foulkes, William D; Boshari, Talia; Davidson, Rosemarie; Ruijs, Marielle.
  • Mikropoulos C; The Institute of Cancer Research, 15 Cotswold Road, Sutton, Surrey SM2 5NG, UK.
  • Selkirk CGH; The John and Carol Walter Center for Urological Health, Department of Surgery, North Shore University Health System, Evanston, IL 60201, USA.
  • Saya S; Center for Medical Genetics, Department of Medicine, NorthShore University HealthSystem, Evanston, IL 60201, USA.
  • Bancroft E; The Institute of Cancer Research, 15 Cotswold Road, Sutton, Surrey SM2 5NG, UK.
  • Vertosick E; The Institute of Cancer Research, 15 Cotswold Road, Sutton, Surrey SM2 5NG, UK.
  • Dadaev T; Royal Marsden NHS Foundation Trust, Fulham Rd, London SW3 6JJ, UK.
  • Brendler C; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
  • Page E; The Institute of Cancer Research, 15 Cotswold Road, Sutton, Surrey SM2 5NG, UK.
  • Dias A; The John and Carol Walter Center for Urological Health, Department of Surgery, North Shore University Health System, Evanston, IL 60201, USA.
  • Evans DG; The Institute of Cancer Research, 15 Cotswold Road, Sutton, Surrey SM2 5NG, UK.
  • Rothwell J; The Institute of Cancer Research, 15 Cotswold Road, Sutton, Surrey SM2 5NG, UK.
  • Maehle L; Royal Marsden NHS Foundation Trust, Fulham Rd, London SW3 6JJ, UK.
  • Axcrona K; Genomic Medicine, Manchester Academic Health Sciences Centre, Division of Evolution and Genomic Sciences, University of Manchester, Central Manchester University Hospitals NHS Foundation Trust, Manchester M13 9WL, UK.
  • Richardson K; Genomic Medicine, Manchester Academic Health Sciences Centre, Division of Evolution and Genomic Sciences, University of Manchester, Central Manchester University Hospitals NHS Foundation Trust, Manchester M13 9WL, UK.
  • Eccles D; Department of Medical Genetics, Oslo University Hospital, Oslo 0372, Norway.
  • Jensen T; Akershus University Hospital, Lørenskog 1478, Norway.
  • Osther PJ; Parkville Familial Cancer Centre, Peter MacCallum Cancer Centre, East Melbourne, VIC 3000, Australia.
  • van Asperen CJ; The Sir Peter MacCallum Department of Oncology, University of Melbourne, VIC 3010, Australia.
  • Vasen H; Wessex Clinical Genetics Service, Princess Anne Hospital, Southampton SO16 5YA, UK.
  • Kiemeney LA; Cancer Sciences, Faculty of Medicine, University of Southampton, University Hospital Southampton NHS Foundation Trust, Southampton SO16 6YD, UK.
  • Ringelberg J; Department of Clinical Genetics, Vejle Hospital, Vejle 7100, Denmark.
  • Cybulski C; Department of Clinical Genetics, Vejle Hospital, Vejle 7100, Denmark.
  • Wokolorczyk D; Leiden University Medical Center, Department of Clinical Genetics, Leiden, ZA 2333, The Netherlands.
  • Hart R; Netherlands Foundation for the Detection of Hereditary Tumors, Leiden, ZA 2333, The Netherlands.
  • Glover W; Radboud University Medical Center, Nijmegen, GA 6525, The Netherlands.
  • Lam J; Netherlands Foundation for the Detection of Hereditary Tumors, Leiden, ZA 2333, The Netherlands.
  • Taylor L; International Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University, Szczecin 70-204, Poland.
  • Salinas M; International Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University, Szczecin 70-204, Poland.
  • Feliubadaló L; Clinical Genetics Unit, Birmingham Women's Hospital, Birmingham B15 2TG, UK.
  • Oldenburg R; Clinical Genetics Unit, Birmingham Women's Hospital, Birmingham B15 2TG, UK.
  • Cremers R; Department of Urology, Repatriation General Hospital, Daw Park, SA 5041, Australia.
  • Verhaegh G; Department of Urology, Repatriation General Hospital, Daw Park, SA 5041, Australia.
  • van Zelst-Stams WA; Hereditary Cancer Program, Catalan Institute of Oncology (ICO-IDIBELL, CIBERONC), L'Hospitalet de Llobregat, Barcelona 08908, Spain.
  • Oosterwijk JC; Hereditary Cancer Program, Catalan Institute of Oncology (ICO-IDIBELL, CIBERONC), L'Hospitalet de Llobregat, Barcelona 08908, Spain.
  • Cook J; Department of Clinical Genetics, Erasmus Medical Center, Rotterdam 3015 CE, The Netherlands.
  • Rosario DJ; Radboud University Medical Center, Nijmegen, GA 6525, The Netherlands.
  • Buys SS; Radboud University Medical Center, Nijmegen, GA 6525, The Netherlands.
  • Conner T; Netherlands Foundation for the Detection of Hereditary Tumors, Leiden, ZA 2333, The Netherlands.
  • Domchek S; Department of Genetics, University Medical Center Groningen, University of Groningen, Groningen 9713 GZ, The Netherlands.
  • Powers J; Sheffield Clinical Genetics Service, Sheffield Children's Hospital, Sheffield S10 2TH, UK.
  • Ausems MG; Royal Hallamshire Hospital, Sheffield S10 2JF, UK.
  • Teixeira MR; Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT 84103, USA.
  • Maia S; Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT 84103, USA.
  • Izatt L; Basser Research Center, University of Pennsylvania, Philadelphia, PA 19104, USA.
  • Schmutzler R; Basser Research Center, University of Pennsylvania, Philadelphia, PA 19104, USA.
  • Rhiem K; Department of Genetics, University Medical Centre Utrecht, Utrecht, CX, The Netherlands.
  • Foulkes WD; Genetics Department and Research Center, Portuguese Oncology Institute, Porto 4200-072, Portugal.
  • Boshari T; Biomedical Sciences Institute (ICBAS), Porto University, Porto 4200-072, Portugal.
  • Davidson R; Genetics Department and Research Center, Portuguese Oncology Institute, Porto 4200-072, Portugal.
  • Ruijs M; South East Thames Genetics Service, Guy's Hospital, London SE1 9RT, UK.
Br J Cancer ; 118(2): 266-276, 2018 01.
Article en En | MEDLINE | ID: mdl-29301143
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Calicreínas / Antígeno Prostático Específico Tipo de estudio: Diagnostic_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Límite: Adult / Aged / Humans / Male / Middle aged Idioma: En Año: 2018 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Calicreínas / Antígeno Prostático Específico Tipo de estudio: Diagnostic_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Límite: Adult / Aged / Humans / Male / Middle aged Idioma: En Año: 2018 Tipo del documento: Article